| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.38B | 26.43B | 24.97B | 22.57B | 20.45B | 18.25B |
| Gross Profit | 5.76B | 6.30B | 5.68B | 5.27B | 4.81B | 4.38B |
| EBITDA | 3.23B | 3.53B | 3.24B | 2.96B | 2.67B | 2.34B |
| Net Income | 2.34B | 2.50B | 2.37B | 2.11B | 2.21B | 1.63B |
Balance Sheet | ||||||
| Total Assets | 28.59B | 30.72B | 28.56B | 26.62B | 24.31B | 22.27B |
| Cash, Cash Equivalents and Short-Term Investments | 17.00B | 18.12B | 16.20B | 14.19B | 13.05B | 11.85B |
| Total Debt | 360.54M | 0.00 | 10.13M | 17.02M | 23.28M | 16.82M |
| Total Liabilities | 6.89B | 6.45B | 7.03B | 6.91B | 6.40B | 6.17B |
| Stockholders Equity | 21.70B | 24.28B | 21.53B | 19.71B | 17.91B | 16.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.33B | 2.57B | 1.83B | 2.06B | 1.62B |
| Operating Cash Flow | 0.00 | 2.51B | 2.77B | 1.85B | 2.09B | 1.65B |
| Investing Cash Flow | 0.00 | -376.46M | -506.84M | -121.89M | -1.21B | -318.93M |
| Financing Cash Flow | 0.00 | -308.66M | -302.26M | -582.60M | -267.83M | -617.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.78B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
75 Outperform | ¥25.80B | 10.52 | ― | 1.21% | 5.85% | 5.71% | |
74 Outperform | ¥26.57B | 11.87 | ― | 2.45% | 8.50% | 2.04% | |
71 Outperform | ¥21.43B | 10.82 | ― | 1.70% | 15.21% | 12.50% | |
69 Neutral | ¥31.97B | 8.54 | ― | 2.22% | 12.35% | 56.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
44 Neutral | ¥20.54B | -6.86 | ― | ― | 20.62% | 36.84% |